Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (331-340 of 443) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationAli Bazarbachi, Myriam Labopin, Mahmoud Aljurf, et al.
Haematologica|November 14, 2015
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMTBipin N Savani, Myriam Labopin, Didier Blaise, et al.
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute LeukemiaRoni Shouval, Annalisa Ruggeri, Myriam Labopin, et al.
ESMO Open|October 24, 2020
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow TransplantationChristoph E Heilig, Manuela Badoglio, Myriam Labopin, et al.
Blood Cancer Journal|May 27, 2024
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMTYishan Ye, Myriam Labopin, Jia Chen, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Leukemia|July 24, 2024
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamideSimona Piemontese, Myriam Labopin, Goda Choi, et al.
Oncotarget|June 3, 2016
RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMTFrédéric Baron, Annalisa Ruggeri, Eric Beohou, et al.
Bone Marrow Transplantation|July 14, 2022
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, et al.
Pageof 45

Showing results (331-340 of 443) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationAli Bazarbachi, Myriam Labopin, Mahmoud Aljurf, et al.
Haematologica|November 14, 2015
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMTBipin N Savani, Myriam Labopin, Didier Blaise, et al.
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute LeukemiaRoni Shouval, Annalisa Ruggeri, Myriam Labopin, et al.
ESMO Open|October 24, 2020
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow TransplantationChristoph E Heilig, Manuela Badoglio, Myriam Labopin, et al.
Blood Cancer Journal|May 27, 2024
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMTYishan Ye, Myriam Labopin, Jia Chen, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Leukemia|July 24, 2024
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamideSimona Piemontese, Myriam Labopin, Goda Choi, et al.
Oncotarget|June 3, 2016
RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMTFrédéric Baron, Annalisa Ruggeri, Eric Beohou, et al.
Bone Marrow Transplantation|July 14, 2022
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, et al.
Pageof 45